Pelvic Inflammatory Disease Does Not Occur in Males
No, males cannot develop Pelvic Inflammatory Disease (PID) because they lack the anatomical structures—uterus, fallopian tubes, and ovaries—that define this condition. 1, 2, 3
Why PID is Female-Specific
PID is explicitly defined as infection and inflammation of the upper female genital tract, including the uterus, fallopian tubes, ovaries, peritoneal surfaces, and contiguous structures. 1, 2, 3 The pathogenesis involves ascending spread of microorganisms from the vagina and endocervix to these upper-genital sites—anatomical structures that males do not possess. 1, 3
The Male Equivalent: Urethritis and Epididymitis
While males cannot develop PID, they can develop infections with the same causative organisms (Chlamydia trachomatis and Neisseria gonorrhoeae) that cause PID in women. 4 In males, these pathogens cause:
These conditions can remain asymptomatic or minimally symptomatic, allowing unknowing transmission to female sexual partners. 4
Critical Role of Males in PID Prevention
Males play an essential role in the PID prevention chain, even though they cannot develop the disease themselves. 1, 5
Partner Treatment is Mandatory
- Male partners of women with PID must be examined and treated if they had sexual contact within 60 days preceding symptom onset. 5
- Treatment is imperative because untreated male partners are the primary source of reinfection in women, with many reinfections traced directly to the original source partner. 1, 5
- Male partners should receive empiric treatment with ceftriaxone 500 mg IM plus azithromycin 1 g orally in a single dose, covering both gonorrhea and chlamydia, regardless of whether pathogens were isolated from the female partner. 5
Prevention Strategy
- Prevention of lower-genital-tract infection with C. trachomatis and N. gonorrhoeae in both men and women is the primary strategy for preventing PID. 1
- Sexually active males should be encouraged to undergo STD testing. 1
- Identifying and treating asymptomatic male carriers prevents PID development in female partners. 1, 4
Common Clinical Pitfall
A critical error is failing to treat male partners empirically even when the female partner's tests are negative or when the male partner is asymptomatic. 5 The pattern of recurrent PID in women strongly suggests ongoing transmission from an untreated partner, and false-negative test results are possible. 5